• In this collection we highlight and provide novel insights into important clinical and translational advances in the management of castration-resistant prostate cancer (CRPC)

  • twitter logo

    Interact with PCan like never before, and get the latest news and research delivered straight to your feed. Also on Twitter! @pcan_journal

Prostate Cancer and Prostatic Diseases is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


collection image

Editors Choice 2022

The Editor of Prostate Cancer and Prostatic Diseases is delighted to share with you this Editor's Choice collection featuring some of the best research and reviews published in the journal in 2022. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers.